Your browser doesn't support javascript.
loading
Dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin neoadjuvant chemotherapy in bladder cancer: ready for prime time?
Pouessel, Damien; Gauthier, Hélène; Serrate, Camille; Pfister, Christian; Culine, Stéphane.
Affiliation
  • Pouessel D; Hôpital Saint-Louis, Université Paris-Diderot, Paris, France.
  • Gauthier H; Hôpital Saint-Louis, Université Paris-Diderot, Paris, France.
  • Serrate C; Hôpital Saint-Louis, Université Paris-Diderot, Paris, France.
  • Pfister C; University Hospital, Rouen, France.
  • Culine S; Hôpital Saint-Louis, Université Paris-Diderot, Paris, France stephane.culine@sls.aphp.fr.
J Clin Oncol ; 32(36): 4168-9, 2014 Dec 20.
Article in En | MEDLINE | ID: mdl-25385728

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Urinary Bladder Neoplasms / Carcinoma, Transitional Cell / Antineoplastic Combined Chemotherapy Protocols / Biomarkers, Tumor / Cystectomy / Granulocyte Colony-Stimulating Factor / Protective Agents / Neoadjuvant Therapy Limits: Female / Humans / Male Language: En Journal: J Clin Oncol Year: 2014 Document type: Article Affiliation country: Francia

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Urinary Bladder Neoplasms / Carcinoma, Transitional Cell / Antineoplastic Combined Chemotherapy Protocols / Biomarkers, Tumor / Cystectomy / Granulocyte Colony-Stimulating Factor / Protective Agents / Neoadjuvant Therapy Limits: Female / Humans / Male Language: En Journal: J Clin Oncol Year: 2014 Document type: Article Affiliation country: Francia